Using an influenza surveillance system to estimate the number of SARS-CoV-2 infections in Beijing, China, weeks 2 to 6 2023-Reference-Cited by-同舟云学术

Using an influenza surveillance system to estimate the number of SARS-CoV-2 infections in Beijing, China, weeks 2 to 6 2023

Published:2023-03-16 Issue:11 Volume:28 Page:
ISSN:1560-7917
Container-title:Eurosurveillance
language:en
Short-container-title:

Author:

Zhang Li¹^ORCID,Zhang Yi²,Duan Wei¹,Wu Shuangsheng¹,Sun Ying¹,Ma Chunna¹,Wang Quanyi¹,Zhang Daitao¹,Yang Peng¹

Affiliation:

1. Beijing Center for Disease Prevention and Control, Dongcheng District, Beijing, China

2. General Administration of Customs (Beijing) International Travel Health Care Center, Dongcheng District, Beijing, China

Abstract

With COVID-19 public health control measures downgraded in China in January 2023, reported COVID-19 case numbers may underestimate the true numbers after the SARS-CoV-2 Omicron wave. Using a multiplier model based on our influenza surveillance system, we estimated that the overall incidence of SARS-CoV-2 infections was 392/100,000 population in Beijing during the 5 weeks following policy adjustment. No notable change occurred after the Spring Festival in early February. The multiplier model provides an opportunity for assessing the actual COVID-19 situation.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

Reference17 articles.

1. Chinese Center for Disease Control and Prevention (Chinese CDC). Epidemic situation of novel coronavirus infection in China. Beijing: Chinese CDC. [Accessed: 3 Feb 2023]. Chinese. Available from: https://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_13141/202302/t20230201_263576.html

2. Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis.;Pan;Lancet,2023

3. Emergence and geographic dominance of Omicron subvariants XBB/XBB.1.5 and BF.7 - the public health challenges.;Velavan;Int J Infect Dis,2023

4. Genomic surveillance of SARS-CoV-2 positive passengers on flights from China to Italy, December 2022.;Novazzi;Euro Surveill,2023

5. National Health Commission of the People’s Republic of China. Notification regarding the print and distribution of the protocol of managing SARS-CoV-2 infection as category B infectious diseases. The Joint Prevention and Control Mechanism of The State Council for novel coronavirus infection. Beijing: National Health Commission. [Accessed: 1 Feb 2023]. Chinese. Available from: http://www.nhc.gov.cn/xcs/zhengcwj/202212/e97e4c449d7a475794624b8ea12123c6.shtml

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitigated transmission and health impact of COVID-19 in Beijing, China during spring 2024: Comparison with the global trends;Science Bulletin;2024-08

2. Spatiotemporal infection dynamics: Linking individual movement patterns to infection status;Cities;2024-07

3. Effectiveness of the six-step approach guided online training program to improve knowledge of Mycoplasma pneumoniae pneumonia among pediatricians: a pretest-posttest study;Translational Pediatrics;2024-05

4. A mini review of reinfection with the SARS‐CoV‐2 Omicron variant;Health Science Reports;2024-04

5. CT-based Assessment at 6-Month Follow-up of COVID-19 Pneumonia patients in China;Scientific Reports;2024-02-29